Atlas Trials

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Clinical trial NCT03661125 · UNKNOWN

Trial details

NCT number
NCT03661125
Sponsor
King's College London
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Parkinson Disease Psychosis
Start date
2019-04-11
Primary completion
2021-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.